Nina Peterson, CANS
Nina Peterson is a Certified Aesthetic Nurse Specialist (CANS) specializing in facial contouring and non-surgical mini facelifts with PDO threads. With over nine years of experience gained in dermatology and plastic surgery practices, Nina also works as a medical blogger and consultant for aesthetic practices and licensed individuals, bringing her background in plastic surgery and dermatology to provide valuable insights.
author’s articles
Liztox vs Nabota – How Do The Korean Botulinum Toxins Compare?
With over 9 million botulinum toxin injections administered globally in a single year, according to the International Society of Aesthetic...
Read More
Liztox Manufacturer – About Huons Biopharma Co., Ltd.
Did you know that 9.8 million botulinum toxin type A injections were administered in the United States in 2024? According...
Read More
How to Buy SCULPTRA® on Medica Depot
It has never been easier to order SCULPTRA® dermal fillers to stock your medical practice. Medica Depot is the absolute...
Read More
How To Buy RESTYLANE® Fillers on Medica Depot
You’re looking to order RESTYLANE® dermal fillers to stock your medical practice? Congratulations – you’ve found the absolute best place...
Read More
Saphnelo FDA Approval Status
In 2021, the FDA granted approval to two important targeted therapies for lupus: voclosporin for lupus nephritis and anifrolumab for...
Read More
The Regenerative Aesthetics Guide: Exosomes, Stem Cells, and What’s Next in Skincare
What Is Regenerative Aesthetics? In recent years, regenerative aesthetics has emerged as one of the most talked-about frontiers in skin...
Read More
Saphnelo Generic Name – Anifrolumab
In a post hoc pooled analysis of the TULIP-1 and TULIP-2 Phase III trials, patients treated with anifrolumab—the generic name...
Read More
Saphnelo Prescribing Information For Practitioners
A 2022 publication from the US Food and Drug Administration (FDA) highlighted the critical role of prescribing information as the...
Read More
How Long Does Saphnelo Stay In Your System?
A 2020 Phase 3 TULIP-2 trial demonstrated the efficacy of Saphnelo (anifrolumab) in treating systemic lupus erythematosus (SLE), with 47.8%...
Read More
How Does Saphnelo Work?
Systemic lupus erythematosus (SLE) is a complex autoimmune disease that arises from a combination of genetic, hormonal, and environmental factors,...
Read More